Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
The therapeutic activity of AMERGE for the treatment of migraine headache is thought to be due to the agonist effects at the 5-HT1B/1D receptors on intracranial blood vessels (including the arterio-venous anastomoses) and sensory nerves of the trigeminal system
Formula: C35H42N4O6
CAS Number: 880813-42-3
SM16 inhibits TGFβ-induced plasminogen activator inhibitor-luciferase activity (IC50=64 nM) and TGFβ- or activin-induced Smad2 phosphorylation at concentrations between 100 and 620 nM
administration MEN11467 weakly inhibits the GR 73632-induced foot tapping behaviour in gerbil (ED50=2
PI3K/mTOR Inhibitor-1 306 (TsOH) The therapeutic activity of AMERGEPI3K mTOR Inhibitor 1 is a potent, orally bioavailable dual PI3K mTOR inhibitor with IC50s of 20 376 204 46 nM and 186 nM for PI3K PI3K PI3K PI3K and mTOR, respectively. Antitumor activity. Product information CAS Number: 1949802 49 6 Molecular Weight: 407. 46 Formula: C18H22FN5O3S Chemical Name: 4 fluoro 5 [6 (1 methanesulfonylcyclopropyl) 2 [(3S) 3 methylmorpholin 4 yl]pyrimidin 4 yl]pyridin 2 amine Smiles: